Minimally invasive image-guided therapy of primary and metastatic pancreatic cancer

Table 3 Studies evaluating intraoperative irreversible electroporation of pancreatic cancer

Author	Patients	Median OS(mo)	Guidancemodality	Major adverse events
Paiella et al[53], 2015	10	7.5	US	20%
Martin et al[48], 2015	200	24.9	US	22%
Kluger et al[52], 2015	50	7.7	Not reported	38%
Lambert et al[54], 2015	21	10.2	Not reported	24%
Yan et al[57], 2016	25	Not reported	US	16%
Vogel et al[50], 2017	15	16	US	53%
Huang et al[47], 2018	70	22.6	US	4%
Yang et al[105], 2020	74	53% (3 yr)1	US	12%
He et al[106], 2020	36	53.5% (2 yr)2	US	5%
He et al[49], 2020	167	16	US	N/A

¹Survival probability at 3-year.

²Survival probability at 2-year. US: Ultrasound.